AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 196 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $28,000 | -50.9% | 2,150 | -48.2% | 0.00% | -66.7% |
| Q4 2020 | $57,000 | +5600.0% | 4,150 | +5828.6% | 0.00% | – |
| Q3 2020 | $1,000 | -92.3% | 70 | -97.2% | 0.00% | -100.0% |
| Q3 2019 | $13,000 | 0.0% | 2,500 | +25.0% | 0.00% | 0.0% |
| Q2 2019 | $13,000 | 0.0% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $13,000 | 0.0% | 2,000 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $13,000 | +85.7% | 2,000 | +100.0% | 0.00% | +100.0% |
| Q3 2018 | $7,000 | +250.0% | 1,000 | +100.0% | 0.00% | – |
| Q2 2018 | $2,000 | -80.0% | 500 | -75.0% | 0.00% | -100.0% |
| Q1 2018 | $10,000 | -56.5% | 2,000 | -60.0% | 0.00% | -50.0% |
| Q4 2017 | $23,000 | +109.1% | 5,000 | +150.0% | 0.00% | +100.0% |
| Q3 2017 | $11,000 | -65.6% | 2,000 | -60.0% | 0.00% | -66.7% |
| Q2 2017 | $32,000 | -55.6% | 5,000 | -50.0% | 0.01% | -14.3% |
| Q1 2017 | $72,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |